Status:
UNKNOWN
Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome
Lead Sponsor:
Assiut University
Conditions:
High Bolus Dose of Tirofiban
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
The goal of the study to investigate the impact of upstream HBD of Tirofiban on short outcome of STEMI patient.
Detailed Description
* Primary percutaneous coronary intervention (PPCI) is the gold standard of treatment of ST segment elevation myocardial infarction (STEMI).1 PPCI restores thrombolysis in myocardial infarction flow 3...
Eligibility Criteria
Inclusion
- \- Acute STEMI patient within 12 hours of chest pain
Exclusion
- -previous infarction in the same infarct- related artery
- ISR
- Resistent cardiogenic shock
- Known CKD with Cr cl less than 60 ml/min
- Uncontrolled HTN more than 180/110 mmHg
- Suspected aortic dissection
- Traumatic or prolonged CPR
- Severe trauma or major surgery within 3 month
- Active peptic ulcer within past 3 month
- Known history of coagulopathy
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 28 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04111289
Start Date
November 1 2019
End Date
January 28 2022
Last Update
October 1 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.